Is ejection fraction in heart failure a limitation or an opportunity? - Wikidata - awgldk - TriplyDB

Is ejection fraction in heart failure a limitation or an opportunity?

Is ejection fraction in heart failure a limitation or an opportunity?

http://www.wikidata.org/entity/Q50048615

about

Is ejection fraction in heart failure a limitation or an opportunity?

http://www.wikidata.org/entity/Q50048615

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Is ejection fraction in heart failure a limitation or an opportunity?

@en

Is ejection fraction in heart failure a limitation or an opportunity?

@nl

type

label

Is ejection fraction in heart failure a limitation or an opportunity?

@en

Is ejection fraction in heart failure a limitation or an opportunity?

@nl

prefLabel

Is ejection fraction in heart failure a limitation or an opportunity?

@en

Is ejection fraction in heart failure a limitation or an opportunity?

@nl

P1433

Q50048615-E3CC50FA-2815-4412-802E-013696CE9A23

P1476

Q50048615-E3D4469A-F8AF-4B4B-A988-2592208C123C

P2093

Q50048615-07D39630-6BE0-4551-86A2-EE177C30E10B

Q50048615-21C71195-4B77-4743-97ED-B04944E5BA37

Q50048615-FD88B9FF-783C-43CE-914F-F1FF02964AF6

P2860

Q50048615-23460EE6-4962-471D-93AF-DFFE147BFBD5

Q50048615-28B879B1-C0BD-40C0-9EDA-7C783A3AA7DA

Q50048615-34A629B6-1B73-4258-A7BA-4AA64DF29E30

Q50048615-41CC791C-F57E-4BA7-81D8-2D4571102577

Q50048615-86499CEE-F808-420A-B523-4EE22DEB33C5

Q50048615-8A4727A0-CFB7-4FA4-A500-CF580382168A

Q50048615-8C020B90-2B0F-4F3E-BCDF-4544B1D98871

Q50048615-92E11A97-70A8-4C6B-8CFD-55D0FA78012D

Q50048615-95B110F2-12D9-41A4-8E39-F277BFA04631

Q50048615-C77A0E12-C26E-49C0-9F4E-8568B554610E

P31

Q50048615-D3885201-ACCD-44D4-BD9F-168AE55CD838

P356

Q50048615-5C2B0B45-7A7E-4BC6-95F3-A2A731090474

P577

Q50048615-6A2704E3-369B-4411-A33D-FF6A896B15E2

P698

Q50048615-898C653E-0F64-43AB-A3E3-FD7D5CC2BB4E

P356

P1433

European Journal of Heart Failure

P1476

Is ejection fraction in heart failure a limitation or an opportunity?

@en

P2093

Gianluigi Savarese

http://www.w3.org/2001/XMLSchema#string

Lars H Lund

http://www.w3.org/2001/XMLSchema#string

Ola Vedin

http://www.w3.org/2001/XMLSchema#string

P2860

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.

Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.

Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.

Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.

A comprehensive population-based characterization of heart failure with mid-range ejection fraction.

What have we learned about heart failure with mid-range ejection fraction one year after its introduction?

P31

scholarly article

P356

10.1002/EJHF.1106

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29333631

http://www.w3.org/2001/XMLSchema#string